Crinetics Pharmaceuticals (CRNX) Net Cash Flow (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 471.36 Bn | 466.57 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.47 Bn | 116.22 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 8 | Argenx Se | 56.08 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 8.72 Bn | 7.43 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.29% |
| Dec 31, 2025 | -117.07% |
| Sep 30, 2025 | 239.99% |
| Jun 30, 2025 | 75.97% |
| Mar 31, 2025 | -222.39% |
| Dec 31, 2024 | -449.00% |
| Sep 30, 2024 | 116.11% |
| Jun 30, 2024 | -127.49% |
| Mar 31, 2024 | 487.98% |
| Dec 31, 2023 | -185.14% |
| Sep 30, 2023 | 6,391.41% |
| Jun 30, 2023 | -119.26% |
| Mar 31, 2023 | 383.87% |
| Dec 31, 2022 | 105.76% |
| Sep 30, 2022 | 63.27% |
| Jun 30, 2022 | -50.97% |
| Mar 31, 2022 | -240.83% |
| Dec 31, 2021 | 327.21% |
| Sep 30, 2021 | -123.55% |
| Jun 30, 2021 | 485.91% |